Stay updated on Lebrikizumab Long-term Safety Efficacy AD Clinical Trial
Sign up to get notified when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.

Latest updates to the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check15 days agoChange DetectedAdded Revision: v3.4.1. Removed the notice about lapse in government funding and the prior Revision: v3.4.0.SummaryDifference0.1%

- Check22 days agoChange DetectedA top-of-page notice informs users about a lapse in government funding and possible processing delays, and directs users to cc.nih.gov for operating status and opm.gov for updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedAdded a glossary toggle and new metadata fields such as Last Update Submitted that Met QC Criteria and Last Update Posted, plus a new Revision: v3.4.0. Older items were removed or renamed, including Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page shows a minor update: Revision: v3.3.4 replaces v3.3.3. No substantive changes to study content were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check65 days agoChange DetectedThe Locations section was expanded to include a global list of study sites, expanding geographic coverage; several location groupings were removed, altering the available sites.SummaryDifference2%

Stay in the know with updates to Lebrikizumab Long-term Safety Efficacy AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.